![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 49, 38482-38485, December 8, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Biochemistry, Duke University Medical
Center, Durham, North Carolina 27710
Received for publication, August 29, 2000
The copper- and zinc-containing superoxide
dismutase can catalyze the oxidation of ferrocyanide by
O The family of superoxide dismutases
(SODs)1 encompasses enzymes
containing copper + zinc (1), manganese (2), iron (3), or nickel (4) at
their active sites. They provide a defense against oxidative stress by
catalyzing the dismutation of O That these ruminations can have biological relevance is shown by the
findings that desulfoferrodoxin substitutes for SOD in SOD-null
Escherichia coli by acting as a SOR (7, 8) and by the
similar action of neelaredoxin (9, 10). It had been proposed earlier
that a manganic porphyrin studied as a mimic of SOD was actually acting
as a SOR (11). It appeared possible that the Cu,Zn-SOD might itself act
as a SOR and/or SOO under special conditions. If so, it would provide
an explanation for the deleterious effects that have been associated
with the overproduction or overadministration of this enzyme
(12-14).
We chose to investigate the ferrocyanide (Fe(II))/ferricyanide
(Fe(III)) couple as the electron donor/acceptor couple for studies of
the SOR/SOO activity of Cu,Zn-SOD for several reasons. Thus, the
conversion of Fe(II) to Fe(III) can be followed at 420 nm (15): Fe(II)
is not autoxidizable to a noticeable degree; Fe(II) has already been
shown to reduce the active site Cu(II) of Cu,Zn-SOD (16); and the rate
of spontaneous reduction of Fe(III) by O K4Fe(CN)6 was from Fisher Scientific,
K3Fe(CN)6 was from J. T. Baker, Inc., MOPS
and DETAPAC were from Sigma, acetaldehyde was from Aldrich, catalase
and Cu,Zn-SOD were from Grunenthal Gmbh, and Mn-SOD was from Human
Biotechnology General Corp., Inc. Bovine cream xanthine oxidase (XO)
was prepared by Ralph Wiley (18). Acetaldehyde was freshly distilled
each day. It was used as the substrate for XO in place of xanthine
because urate rapidly reduced Fe(CN)63 Cu,Zn-SOD Catalyzes the Oxidation of Fe(II) by
O The Effects of Varying the Concentration of Cu,Zn-SOD and the
Supply of O Effect of Mn-SOD--
Mn-SOD does not catalyze the oxidation
for Fe(II) by O
Catalase added to 100 units/ml was without effect on the
O A Superoxide: Ferricyanide Oxidoreductase Activity of
Cu,Zn-SOD--
O We have seen that Cu,Zn-SOD can catalyze the dismutation of
O SOD activity depends upon the sum of Reactions 1 and 2 as noted
earlier. The SOR activity involves Reactions 3 and 2, whereas the SOO
activity involves Reactions 4 and 1.
Copper- and Zinc-containing Superoxide Dismutase Can Act as a
Superoxide Reductase and a Superoxide Oxidase*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
2 as well as the reduction of ferricyanide by O
2.
Thus, it can act as a superoxide dismutase (SOD), a superoxide
reductase (SOR), and a superoxide oxidase (SOO). The human
manganese-containing SOD does not exert SOR or SOO activities with
ferrocyanide or ferricyanide as the redox partners. It is possible that
some biological reductants can take the place of ferrocyanide and can
also interact with human manganese-containing superoxide dismutase,
thus making the SOR activity a reality for both SODs. The consequences
of this possibility vis à vis
H2O2 production, the overproduction of SODs,
and the role of copper- and zinc-containing superoxide dismutase
mutations in causing familial amyotrophic lateral sclerosis are
discussed, as well as the likelihood that the biologically effective
SOD mimics, as described to date, actually function as SORs.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
2 into
H2O2 plus O2 and do so at close to
the limit imposed by diffusional encounters (5, 6). Their mechanism of
action is based upon the reduction and reoxidation of the catalytic
metal center by O
2 as illustrated in reactions 1 and 2 for the
case of Cu,Zn-SOD.
and
If an electron donor other than O
2 was to reduce the
active site Cu(II) to Cu(I), the SOD would then act as a
reductant:O
2 oxidoreductase, i.e. as a
superoxide reductase (SOR). On the other hand, if an electron acceptor
was to replace O
2 in reoxidizing the Cu(I) to Cu(II), the
enzyme would then act as a superoxide oxidase (SOO).
2 is slow with a rate
constant at 25 °C of ~2.7 × 102
M
1 s
1 (17). In what follows, we
demonstrated that Cu,Zn-SOD can act as a Fe(II):O
2
oxidoreductase (i.e. as a SOR) and an O
2:Fe(III) oxidoreductase (i.e. as a SOO), and we discussed the
possible consequences of these activities.
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
(19) and also because acetaldehyde could be used at 20 mM, allowing relatively large fluxes of O
2 to be maintained
without a significant depletion of the substrate. Reactions were
performed at 23 °C in 50 mM MOPS, 0.1 mM
DETAPAC, 20 mM acetaldehyde, 1.0 mM Fe(II) or
0.5 mM Fe(III), 0.2 mg/ml Cu,Zn-SOD, and enough XO to cause
the production of 12 nmol of O
2/min/ml when Fe(II) oxidation was to be followed and 15 nmol of O
2/min/ml when Fe(III)
reduction was to be followed. The rate of O
2 production was
measured by replacing Fe(II) or Fe(III) with 0.020 mM
ferricytochrome c and decreasing [XO] by a factor of
5. The molar rate of cytochrome c reduction, which
could be 100% inhibited by SOD, was equal to the rate of O
2
production. Fe(II) oxidation or Fe(III) reduction was followed
at 420 nm using E M
1
cm
1 = 1020 (15). Other components when present are
specified in the figure legends.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
2--
SOR activity with Fe(II) as the reductant would
entail the catalysis of the O
2-dependent oxidation
of Fe(II). Line 1 in Fig. 1A shows that Cu,Zn-SOD alone
caused only a stoichiometric oxidation of Fe(II) to Fe(III), whereas
the provision of a flux of O
2 allowed the enzyme to catalyze
that oxidation. Line 2 in Fig. 1A shows that the
flux of O
2 did not cause the oxidation of Fe(II) until Cu,Zn-SOD was added. Thus, Cu,Zn-SOD can act as a SOR with Fe(II) serving as the reductant of the active site Cu(II). Under the conditions used, the rate of Fe(II) oxidation was ~45% of the rate
of O
2 production. Hence, 1.0 mM Fe(II) was unable
to largely outcompete the much lower steady state concentration of
O
2 as the reductant for the active site Cu(II), and the enzyme
was acting simultaneously as a SOD and SOR.

View larger version (24K):
[in a new window]
Fig. 1.
A, Cu,Zn-SOD catalyzes the
O2-dependent oxidation of Fe(II). Reaction
mixtures contained 20 mM acetaldehyde, 0.1 mM
DETAPAC, 0.2 mg/ml Cu,Zn-SOD, 50 mM MOPS, pH 7.8, at
25 °C. Line 1, 1.0 mM Fe(II) was
added at the first arrow, and XO was added at the
second arrow. Line 2, all
components were present except 0.2 mg/ml Cu,Zn-SOD (SOD),
which was added at the arrow. B, effects of
varying [XO], [Fe(II)], and [Cu,Zn-SOD]. Line
3, buffer, DETAPAC, acetaldehyde, and Fe(II)
were present at the outset. 0.2 mg/ml Cu,Zn-SOD was added at the
first arrow, one-fifth the usual amount of XO was
added at the second arrow, and four-fifths the
usual amount of XO was added at the third arrow. Line
4, all components except Cu,Zn-SOD were present at the outset.
0.02 mg/ml Cu,Zn-SOD was added at the first
arrow, and 0.20 mg/ml Cu,Zn-SOD was added at the
second arrow. An additional 4.0 mM
Fe(II) was added at the third arrow.
C, effect of Mn-SOD (see reaction mixture in A).
Line 5, 0.04 mg/ml Cu,Zn-SOD was added at the
arrow. Line 6, 0.04 mg/ml Cu,Zn-SOD was added
with 0.15 mg/ml Mn-SOD present at the outset. Line 7, 0.04 mg/ml Cu,Zn-SOD was added with 0.67 mg/ml Mn-SOD present at the
outset.
2--
Raising the [Cu,Zn-SOD] at a constant
[Fe(II)] should cause a directly proportional increase in the rate of
the reduction of the active site Cu(II) by Fe(II) but a less than
proportional increase in the reduction of the active site Cu(II) by
O
2 because [O
2] falls as [SOD] increases. Thus,
at a constant Fe(II) and constant flux of O
2, raising
[Cu,Zn-SOD] should increase the ratio of SOR to SOD activities.
Conversely, raising [O
2] with other factors that are held
constant should favor SOD activity over SOR activity. Hence, increasing
the rate of production of O
2 does not proportionately increase
SOR activity because a larger fraction of the O
2 is eliminated
by the SOD reactions. In keeping with those expectations, line
3 in Fig. 1B shows again that Cu,Zn-SOD caused a
stoichiometric oxidation of Fe(II) and that the subsequent addition of
graded amounts of XO caused a less than proportional increase in the
rate of Fe(II) oxidation. Thus, increasing [XO] 5-fold, which would
increase the O
2 flux 5-fold, caused only a 2.3-fold increase
in the rate of Fe(II) oxidation. Line 4 shows again that a
flux of O
2 per se was not able to oxidize Fe(II) and that the subsequent addition of graded amounts of Cu,Zn-SOD caused
a less than proportional increase in the rate of Fe(II) oxidation as
did raising the [Fe(II)]. These results are in accordance with
expectations based on the effects of these manipulations on the
[O
2] and on the ratio of Cu(II) to Cu(I) at the active site,
and they are further considered under "Discussion."
2. It could be used to test the effect of
[O
2] on the SOD:SOR ratio. Thus, 0.15 mg/ml Mn-SOD
slowed the oxidation of Fe(II) by the SOR activity of Cu,Zn-SOD
(compare lines 5 and 6 in Fig. 1C), whereas 0.66 mg/ml caused further inhibition, which was less than proportional (line 7) because the SOR:SOD ratio increases as
[O
2] decreases. Such high concentrations of Mn-SOD were
needed also because it was competing for O
2 with the
Cu,Zn-SOD.
2-dependent oxidation of Fe(II) by Cu,Zn-SOD. Moreover,
0.1 mM H2O2 did not replace the
flux of O
2 in facilitating the oxidation of Fe(II) by
Cu,Zn-SOD (data not shown). It follows that there was no detectable
oxidation of Fe(II) by the "peroxidase" activity of Cu,Zn-SOD (20,
21).
2 is known to reduce Fe(III) with a rate
constant of 3 × 102 M
1
s
1 (17), and as shown by line 1 in Fig.
2A, the flux of O
2
produced by the XO reaction (15 nmol/ml/min) caused the reduction of
Fe(III). Cu,Zn-SOD added to 0.002 mg/ml inhibited the rate of Fe(III)
reduction, but adding more did not inhibit further and indeed
increased the rate of Fe(III) reduction. Line 2 presents a
repetition of this experiment but at one-fifth the XO and thus at
one-fifth the flux of O
2. Thus, at a low concentration,
Cu,Zn-SOD inhibits the reduction of Fe(III) by O
2 by
catalyzing the dismutative elimination of O
2, whereas higher
[Cu,Zn-SOD] catalyzes the reduction of Fe(III) by O
2
(i.e. it acts as a superoxide oxidase). When the
concentration of Fe(III) was decreased to 0.1 mM, its rate
of reduction by the flux of O
2 was much lower than that flux
due to the loss of O
2 to the spontaneous dismutation of
O
2. Under these conditions, the SOO activity of Cu,Zn-SOD was
evident at lower concentrations of the enzyme. This is shown by
line 3 in Fig. 2.

View larger version (51K):
[in a new window]
Fig. 2.
Cu,Zn-SOD catalyzes the
O2-dependent reduction of
Fe(III). Reaction mixtures contained 20 mM
acetaldehyde, 0.1 mM DETAPAC, 0.2 mg/ml Cu,Zn-SOD, 0.5 mM Fe(III), 50 mM MOPS, pH 7.8, at 25 °C.
Line 1, XO was added at the first
arrow, 0.002 mg/ml Cu,Zn-SOD (SOD) was added at
the second arrow, 0.004 mg/ml Cu,Zn-SOD was added
at the third arrow, and 0.2 mg/ml Cu,Zn-SOD was
added at the fourth arrow. Line 2,
one-fifth the usual amount of XO was added at the first
arrow, 0.001 mg/ml Cu,Zn-SOD was added at the
second arrow, and 0.2 mg/ml Cu,Zn-SOD was added
at the third arrow. Line 3, 0.1 mM
Fe(III) and XO were added at the first arrow,
0.04 mg/ml Cu,Zn-SOD was added at the second arrow, and 0.2 mg/ml Cu,Zn-SOD was added at the third arrow.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
2, the reduction of O
2 by Fe(II), or the oxidation
of O
2 by Fe(III). That is to say that Cu,Zn-SOD can act as a
SOD, SOR, or SOO. Although these activities were demonstrated using the decidedly unnatural Fe(II)/Fe(III) redox couple, it is possible that in
the reducing environment of the cell, there is some natural redox pair
that can interact with the active site of the Cu,Zn-SOD. Because a
number of otherwise puzzling observations can be explained based on
these multiple activities, it may be worthwhile to express the
component reactions and their relationships more rigorously.
and
The rates of the component reactions can be written as
follows.
(Eq. 1)
(Eq. 2)
(Eq. 3)
Under steady state conditions, the sum of the rates of the
reduction of E
(Eq. 4)
Cu(II) must equal the sum of the
rates of the oxidation of E
Cu(I), hence,
VI + VIII = VII + VIV. In the
presence of a constant flux of O
2 and when [Fe(II)]
[Fe(III)]VIV is negligible and then
or equivalently
(Eq. 5)
(Eq. 6)
When [Cu,Zn-SOD] is increased the VIII
term increases in direct proportion because Fe(II) is in large excess
and is effectively constant, but VI and
VII will not increase proportionately because [O
2] will fall as [Cu,Zn-SOD] increases. It follows that
increasing [Cu,Zn-SOD] will favor SOR activity over SOD activity.
This effect was demonstrated in Fig. 1B. Similarly, raising
Fe(II) will also increase the SOR:SOD ratio.
Anything that decreases [O
2] will favor the SOR reaction
over the SOD reaction. This can be made obvious by rearranging Equation 6.
|
(Eq. 7) |
|
2] falls,
but the SOR:SOD ratio will rise because decreasing [O
2] will
increase the [E
Cu(I)]:[E
Cu(II)] ratio. This is the case because O
2 is
the only oxidant of E
Cu(I) under the
conditions specified. We have seen that decreasing [O
2] by
increasing [Cu,Zn-SOD], by adding Mn-SOD, or by lowering [XO]
increased the SOR:SOD ratio in accordance with these deductions.
The Fe(II)/Fe(III) couple has been shown here to support the SOR and SOO activities of Cu,Zn-SOD but not the activities of Mn-SOD because this redox couple interacts with the active site copper but not with the active site manganese. If the cell contains redox couples competent to interact with both active sites, both Cu,Zn-SOD and Mn-SOD could act as SORs and SOOs. Given that cell cytosols are reducing environments, SOR activity is more likely to occur in vivo than SOO activity.
Whether the SOD enzymes act only in the SOD, SOR, or SOO modes, they
have an effect on the amount of H2O2 produced
from O
2. Thus, in the SOD reaction, 0.5 H2O2 is produced per O
2 consumed, whereas in the SOR mode, 1.0 H2O2 is the
yield per O
2. In the SOO mode, no
H2O2 would be made from O
2. Because we
have seen that lowering [O
2] favors the SOR mode, we deduce
that raising [Cu,Zn-SOD] would increase H2O2
production only in the presence of a reductant capable of reducing the
active site Cu(II). If O
2 were acting to initiate oxidative
chain reactions, then the yield of
H2O2/O
2 could be significantly greater
than 1.0 H2O2/O
2. In such a situation
SODs would decrease H2O2 production.
If an endogenous reductant that can act as a SOR substrate is an
essential molecule or if its oxidized form is toxic, we can understand
the reports that overproduction (13, 14) or overadministration (12) of
SOD has deleterious effects. Thus, increasing [SOD] increases the
SOR:SOD ratio because it lowers [O
2] and at the same time
increases the net SOR action. The neurotoxic effect of the mutant forms
of Cu,Zn-SOD that have been associated with the familial amyotrophic
lateral sclerosis (22) may be because of SOR activity. Thus, the
mutated Cu,Zn-SODs may be able to catalyze the oxidation of essential
reductants within motor neurons by O
2, a SOR activity that is
not exerted by the wild-type enzyme.
O
2 is scavenged very effectively by desulfoferrodoxin
(7, 8) and neelaredoxin (9, 10) acting as SORs. The SOD-mimic O-Mn(III)meso-tetrakis-(N-methylpyridinium-2-yl)porphyrin
(MnTMPyP) has also been reported to act as a SOR within E. coli (11). Given that low molecular weight SOD-mimics are certain
to be less discriminating than the SODs themselves with regard to
interaction with reductants, it seems probable that the biological
effects of most of these mimics are because of SOR rather than SOD
activity. The results of Offer et al. (23) who have reported
that the nitroxide-catalyzed oxidation of Fe(II) by a flux of
O
2 could be inhibited by low [Cu,Zn-SOD] but not by high
[Cu,Zn-SOD] can now be understood in terms of the increase in SOR
activity with increasing [Cu,Zn-SOD] as described above. It should be
stressed that any agent acting as a SOR could be beneficial or
detrimental depending on the nature of the reductant consumed and the
oxidized product generated from thereon, the availability of that
reductant and the possibility of its regeneration, and the magnitude of the flux of O
2 and the availability of critical targets for
O
2 attack. Thus, not only the toxic effects of the nitroxides
as Offer et al. (23) suggest but also their beneficial
actions are explicable on the basis of their SOR activity.
| |
FOOTNOTES |
|---|
* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 919-684-5122;
Fax: 919-684-8885; E-mail: fridovich@biochem.duke.edu.
Published, JBC Papers in Press, September 25, 2000, DOI 10.1074/jbc.M007891200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: SOD, superoxide dismutase; Cu, Zn-SOD, copper- and zinc-containing superoxide dismutase; SOO, superoxide oxidase; SOR, superoxide reductase; Mn-SOD, human manganese-containing superoxide dismutase; Fe(II), potassium ferrocyanide; Fe(III), potassium ferricyanide; MOPS, 4-morpholinepropanesulfonic acid; DETAPAC, diethylenetriaminepentaacetic acid; XO, xanthine oxidase.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | McCord, J. M., and Fridovich, I. (1969) J. Biol. Chem. 224, 6049-6055 |
| 2. | Keele, B. B., McCord, J. M., and Fridovich, I. (1970) J. Biol. Chem. 245, 6176-6181 |
| 3. | Yost, F. J., Jr., and Fridovich, I. (1973) J. Biol. Chem. 248, 4905-4908 |
| 4. | Youn, H.-D., Kim, E.-J., Roe, J.-H., Hah, Y. C., and Kang, S. O. (1996) Biochem. J. 318, 889-896 |
| 5. | Klug, D., Rabani, J., and Fridovich, I. (1972) J. Biol. Chem. 247, 4839-4842 |
| 6. | Rotilio, G., Bray, R. C., and Fielden, E. M. (1972) Biochim. Biophys. Acta 268, 605-609 |
| 7. | Liochev, S. I., and Fridovich, I. (1997) J. Biol. Chem. 272, 25573-25575 |
| 8. | Lombard, M., Fontecave, M., Touati, D., and Nivière, V. (2000) J. Biol. Chem. 275, 115-121 |
| 9. | Lombard, M., Touati, D., Fontecave, M., and Nivière, V. (2000) J. Biol. Chem. 275, 27021-27026 |
| 10. | Jovanovic, T., Ascenso, C., Hazlett, K. R. O., Sikkink, R., Krebs, C., Litwiller, R., Benson, L. M., Moura, I., Moura, J. J. G., Radolf, J. D., Huynh, B. H., Naylor, S., and Rusnak, F. (2000) J. Biol. Chem. 275, 28439-28448 |
| 11. | Faulkner, K. M., Liochev, S. I., and Fridovich, I. (1994) J. Biol. Chem. 269, 23471-23476 |
| 12. | Omar, B. A., Gad, N. M., Jordan, N. C., Striplin, S. P., Russel, W. T., Downey, J. M., and McCord, J. M. (1990) Free Radic. Biol. Med. 9, 465-471 |
| 13. | Amstad, P., Peskin, A., Shah, G., Mirault, M. E., Moret, R., Zbinden, I., and Cerutti, P (1991) Biochemistry 30, 9305-9313 |
| 14. | Scott, M. D., Meshnick, J. R., and Eaton, J. W. (1989) J. Biol. Chem. 264, 2498-2501 |
| 15. | Schellenberg, K. A., and Hellerman, L. (1958) J. Biol. Chem. 231, 547-556 |
| 16. | Rotilio, G., Morpurgo, L., Calabrese, L., and Mondovi, B. (1973) Biochim. Biophys. Acta 302, 229-235 |
| 17. | Zehavi, D., and Rabani, J. (1972) J. Phys. Chem. 76, 3703-3709 |
| 18. | Waud, W. R., Brady, F. O., Wiley, R. D., and Rajagopalan, K. V. (1975) Arch. Biochem. Biophys. 169, 695-701 |
| 19. | Fridovich, I., and Handler, P. (1958) J. Biol. Chem. 233, 1581-1585 |
| 20. | Hodgson, E. K., and Fridovich, I. (1975) Biochemistry 14, 5294-5299 |
| 21. | Hodgson, E. K., and Fridovich, I. (1975) Biochemistry 14, 5299-5303 |
| 22. | Estevez, A., Crow, J. P., Sampson, J. B., Reiter, C., Zhuang, Y., Richardson, G. J., Tarpey, M. M., Barbeito, L., and Beckman, J. S. (1999) Science 286, 2498-2500 |
| 23. | Offer, T., Russo, A., and Samuni, A. (2000) FASEB J. 14, 1215-1223 |
This article has been cited by other articles:
![]() |
B. J. Day and C. Kariya A Novel Class of Cytochrome P450 Reductase Redox Cyclers: Cationic Manganoporphyrins Toxicol. Sci., May 1, 2005; 85(1): 713 - 719. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Emerson, E. D. Coulter, R. S. Phillips, and D. M. Kurtz Jr. Kinetics of the Superoxide Reductase Catalytic Cycle J. Biol. Chem., October 10, 2003; 278(41): 39662 - 39668. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. I. Liochev and I. Fridovich Copper, Zinc Superoxide Dismutase and H2O2. EFFECTS OF BICARBONATE ON INACTIVATION AND OXIDATIONS OF NADPH AND URATE, AND ON CONSUMPTION of H2O2 J. Biol. Chem., September 13, 2002; 277(38): 34674 - 34678. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Hayward, J. A. Rodriguez, J. W. Kim, A. Tiwari, J. J. Goto, D. E. Cabelli, J. S. Valentine, and R. H. Brown Jr. Decreased Metallation and Activity in Subsets of Mutant Superoxide Dismutases Associated with Familial Amyotrophic Lateral Sclerosis J. Biol. Chem., May 3, 2002; 277(18): 15923 - 15931. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Abreu, L. M. Saraiva, C. M. Soares, M. Teixeira, and D. E. Cabelli The Mechanism of Superoxide Scavenging by Archaeoglobus fulgidus Neelaredoxin J. Biol. Chem., October 12, 2001; 276(42): 38995 - 39001. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. I. Liochev and I. Fridovich Copper,Zinc Superoxide Dismutase as a Univalent NO- Oxidoreductase and as a Dichlorofluorescin Peroxidase J. Biol. Chem., September 14, 2001; 276(38): 35253 - 35257. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Winterbourn, A. V. Peskin, and H. N. Parsons-Mair Thiol Oxidase Activity of Copper,Zinc Superoxide Dismutase J. Biol. Chem., January 11, 2002; 277(3): 1906 - 1911. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |